X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Latest Study By ICR Tracks Rare Childhood Cancer Progression

Content Team by Content Team
25th October 2022
in News, Research & Development

The researchers discovered that liquid biopsy blood tests may detect symptoms of a malignancy that has reappeared, evaluate the severity of the condition, and assist in determining the best treatment option for specific individuals.

RMS is an uncommon form of cancer that develops in hollow organs like the bladder or uterus as well as soft tissue, notably skeletal muscle tissue. RMS can strike anyone at any age, although kids are most frequently affected. According to the ICR, less than a third of individuals who relapse or whose cancer has progressed will survive, regardless of the type of RMS, where it starts, the size of the tumour, or whether the cancer has spread.

The research, which was reported in the Journal of Clinical Oncology-Precision Oncology, included mouse experiments as well as blood and tissue samples from 28 RMS patients from various centres throughout Europe.

The researchers investigated whether detecting DNA released into the bloodstream by cancer cells may track the development and intensity of tumours and provide youngsters with a quicker and much less unpleasant alternative to conventional tissue biopsies.

Blood samples were taken from 18 children in the trial before therapy and numerous blood tests were performed throughout treatment to monitor the course of the disease. In this group, 14 out of the 18 patients had significant genetic alterations in their tumours, which suggests that these individuals may profit from more vigorous therapy.

Additionally, the researchers discovered that patients with cancer that had progressed to the lymph nodes and other body areas had higher blood levels of cancer DNA before starting therapy. This was also true for malignancies discovered in difficult-to-treat areas of the body as opposed to those discovered in more accessible locales.

Previous Post

CDC Recommends Novavax COVID Jab To Mix With Pfizer, Moderna

Next Post

HIV Patients Avoid hepatitis B With A Three-Dose Vaccine

Related Posts

DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Drug Development

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

21st March 2025
Clinical Trials

Oracle Wins the Asia Pacific Biopharma Excellence Awards

21st March 2025
Next Post

HIV Patients Avoid hepatitis B With A Three-Dose Vaccine

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In